Teijin's Gout Treatment Drug Headed for Europe, US Markets

摘要

Teijin Pharma's new gout treatment drug TMX-67 is likely to hit markets in Europe this year and the US in 2009. TMX-67 would be the first gout treatment drug to be launched in about 40 years and the first global drug for the Tokyo-based company.